Dr Saied Khosrowpour, MD | |
100 Wheatley Dr, Americus, GA 31709-3788 | |
(229) 924-6011 | |
Not Available |
Full Name | Dr Saied Khosrowpour |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 22 Years |
Location | 100 Wheatley Dr, Americus, Georgia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275552440 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 058305 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Halifax Regional Medical Center Inc | Roanoke rapids, NC | Hospital |
Carolina Pines Regional Medical Center | Hartsville, SC | Hospital |
Cape Fear Valley Hoke Hospital | Raeford, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Ies South Carolina Llc | 1355705070 | 16 |
Hoke Emergency Group, Pc | 7214200146 | 28 |
Vidant Medical Group Llc | 0345343893 | 849 |
News Archive
A stream of hospital administrators, a state assemblyman, doctors and advocates for immigrants took the microphone at a sometimes raucous hearing in Downtown Brooklyn on Thursday to plead with state officials not to close, merge or shrink troubled hospitals in the borough.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
New research from the University of Pennsylvania School of Medicine may help more smokers keep their New Year's resolution by helping them quit smoking. Extended use of a nicotine patch - 24 weeks versus the standard eight weeks recommended by manufacturers - boosts the number of smokers who maintain their cigarette abstinence and helps more of those who backslide into the habit while wearing the patch, according to a study which will be published in the February 2 issue of Annals of Internal Medicine.
› Verified 3 days ago
Entity Name | App Of South Carolina Ed Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457878084 PECOS PAC ID: 3577821107 Enrollment ID: O20180103000650 |
News Archive
A stream of hospital administrators, a state assemblyman, doctors and advocates for immigrants took the microphone at a sometimes raucous hearing in Downtown Brooklyn on Thursday to plead with state officials not to close, merge or shrink troubled hospitals in the borough.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
New research from the University of Pennsylvania School of Medicine may help more smokers keep their New Year's resolution by helping them quit smoking. Extended use of a nicotine patch - 24 weeks versus the standard eight weeks recommended by manufacturers - boosts the number of smokers who maintain their cigarette abstinence and helps more of those who backslide into the habit while wearing the patch, according to a study which will be published in the February 2 issue of Annals of Internal Medicine.
› Verified 3 days ago
Entity Name | Ies South Carolina Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821779695 PECOS PAC ID: 1355705070 Enrollment ID: O20230914000885 |
News Archive
A stream of hospital administrators, a state assemblyman, doctors and advocates for immigrants took the microphone at a sometimes raucous hearing in Downtown Brooklyn on Thursday to plead with state officials not to close, merge or shrink troubled hospitals in the borough.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
New research from the University of Pennsylvania School of Medicine may help more smokers keep their New Year's resolution by helping them quit smoking. Extended use of a nicotine patch - 24 weeks versus the standard eight weeks recommended by manufacturers - boosts the number of smokers who maintain their cigarette abstinence and helps more of those who backslide into the habit while wearing the patch, according to a study which will be published in the February 2 issue of Annals of Internal Medicine.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Saied Khosrowpour, MD 5995 Fording Creek Ln, Kernersville, NC 27284-6367 Ph: (336) 340-4897 | Dr Saied Khosrowpour, MD 100 Wheatley Dr, Americus, GA 31709-3788 Ph: (229) 924-6011 |
News Archive
A stream of hospital administrators, a state assemblyman, doctors and advocates for immigrants took the microphone at a sometimes raucous hearing in Downtown Brooklyn on Thursday to plead with state officials not to close, merge or shrink troubled hospitals in the borough.
K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market CAYMAN Minimally Invasive, the latest addition to the company's CAYMAN product family of plate systems already featuring CAYMAN Anterior, CAYMAN Buttress and CAYMAN Lateral.
Esperance Pharmaceuticals Inc. today reported positive results from a Phase II trial of lead candidate EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 is a targeted membrane-disrupting peptide designed to seek and destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over-expressed in a wide range of cancers.
New research from the University of Pennsylvania School of Medicine may help more smokers keep their New Year's resolution by helping them quit smoking. Extended use of a nicotine patch - 24 weeks versus the standard eight weeks recommended by manufacturers - boosts the number of smokers who maintain their cigarette abstinence and helps more of those who backslide into the habit while wearing the patch, according to a study which will be published in the February 2 issue of Annals of Internal Medicine.
› Verified 3 days ago
Dr. Benjamin Charles Andrews Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Wheatley Dr, Americus, GA 31709 Phone: 229-924-6011 | |
Dr. Brian K. Jordan, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Wheatley Dr, Americus, GA 31709 Phone: 229-924-6011 | |
Dr. Charles Oyakhilomen Ebhohimen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Wheatley Dr, Americus, GA 31709 Phone: 229-924-6011 | |
Donna Onley-harden, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Wheatley Dr, Americus, GA 31709 Phone: 229-924-6011 |